Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?

Multiple system atrophy is a rapidly progressive and fatal neurodegenerative disorder. While numerous preclinical studies suggested efficacy of potentially disease modifying agents, none of those were proven to be effective in large-scale clinical trials. Three major strategies are currently pursued...

Descripción completa

Detalles Bibliográficos
Autores principales: Sidoroff, Victoria, Bower, Pam, Stefanova, Nadia, Fanciulli, Alessandra, Stankovic, Iva, Poewe, Werner, Seppi, Klaus, Wenning, Gregor K., Krismer, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398078/
https://www.ncbi.nlm.nih.gov/pubmed/35491799
http://dx.doi.org/10.3233/JPD-223183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398078/
https://www.ncbi.nlm.nih.gov/pubmed/35491799
http://dx.doi.org/10.3233/JPD-223183

Ejemplares similares